Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression. - Wikidata - wikimedia - TriplyDB

Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.

Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.

http://www.wikidata.org/entity/Q37412467

about

A Stochastic Individual-Based Model of the Progression of Atrial Fibrillation in Individuals and Populations Emergency Department Readmission in Elderly Patients After Acute Rhythm or Rate Control Treatment for Atrial Fibrillation.

P2860

Q35987323-268303A8-AEE4-4FFD-8854-A64422E71976 Q37456935-92CD33EE-C297-46F4-93FB-8A6AB1455635

P2860

Avoiding permanent atrial fibrillation: treatment approaches to prevent disease progression.

http://www.wikidata.org/entity/Q37412467

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Avoiding permanent atrial fibr ...... o prevent disease progression.

@en

Avoiding permanent atrial fibr ...... o prevent disease progression.

@nl

type

label

Avoiding permanent atrial fibr ...... o prevent disease progression.

@en

Avoiding permanent atrial fibr ...... o prevent disease progression.

@nl

prefLabel

Avoiding permanent atrial fibr ...... o prevent disease progression.

@en

Avoiding permanent atrial fibr ...... o prevent disease progression.

@nl

P1433

Q37412467-FF6447D4-16EC-4FAB-B464-00F42A5AF4E5

P1476

Q37412467-8731AB11-ADF7-4D7D-B8CC-E07478EA04EE

P2093

Q37412467-08E896FE-383A-440A-8961-0405115C308E

Q37412467-3D60FF60-42AD-474F-AE77-4B9130C74A48

P275

Q37412467-C8FF75B1-F00C-4E66-BE5C-2FED3D71C2DF

P2860

Q37412467-02495C13-CF97-43D7-8CF5-0B12EE8CE1F9

Q37412467-02EB1165-3991-4C42-B625-2226034BECA9

Q37412467-04412150-506A-4A63-A90B-B5CCBFDCD6E5

Q37412467-0F5579C9-F4BE-45FD-8CBD-90DC9720FB2C

Q37412467-106DD868-EC05-45FB-8E54-375E9CEBE9CB

Q37412467-13310BDF-CEDE-422A-948B-88E5AEFEA614

Q37412467-21341651-BD8F-4675-B9BD-229B09605A8F

Q37412467-220894FA-4724-4357-B79C-4A0B97F70C35

Q37412467-2BAD9333-6C5B-4A46-99A9-8495ADAFB198

Q37412467-2CD67454-70C7-44B6-90FC-42B87BF03C93

P304

Q37412467-988DB7C2-38AE-4FF6-9B78-CE093C264872

P31

Q37412467-058C89CF-4892-4767-958A-93D3169F3DC1

Q37412467-49508324-18E7-4635-83E8-F1F1B2FA2A3E

P356

Q37412467-21694AA2-C981-4265-A782-F87DA497CE89

P407

Q37412467-94C78957-8F46-4D57-AAC6-D8785773689B

P478

Q37412467-917D43AE-5B77-4F01-9CE8-9496E063B2A7

P5008

Q37412467-5CE8545B-3035-492A-AA06-8568A20B4CF3

P577

Q37412467-CA334117-8A3E-4BC4-90E3-32EE2081909A

P698

Q37412467-0F5CC666-7136-47DA-9F89-B3F2E624CBBC

P921

Q37412467-48518BDA-8D1D-4D08-92D9-B55BFA03FE69

Q37412467-5BA900A3-6FFA-443A-AE85-8C42280A3810

Q37412467-7A28DD97-8DE6-4895-909E-41EB6A35A008

Q37412467-D496299E-8B66-4080-9A9A-6020EA6BCF73

Q37412467-F7CB0D11-4306-4BAC-B79F-666E6521164A

P932

Q37412467-0833B6DA-8494-44B0-922D-AF58BE5EF704

P356

P1433

Vascular Health and Risk Management

P1476

Avoiding permanent atrial fibr ...... o prevent disease progression.

@en

P2093

Anne B Curtis

http://www.w3.org/2001/XMLSchema#string

Ashish Shukla

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Antiarrhythmic drug therapy for atrial fibrillation

Practice implications of the Atrial Fibrillation Guidelines

Effect of dronedarone on cardiovascular events in atrial fibrillation

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

Increased mortality after dronedarone therapy for severe heart failure

Association of body mass index, diabetes, hypertension, and blood pressure levels with risk of permanent atrial fibrillation

Dronedarone in High-Risk Permanent Atrial Fibrillation

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S49334

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24379678

http://www.w3.org/2001/XMLSchema#string

P921

cerebrovascular disease

preventive health services

atrial fibrillation

P932

3872084

http://www.w3.org/2001/XMLSchema#string